Why the study?
Does percutaneous balloon dilatation reduce aortic valve pressure gradients and improve clinical outcomes in neonates and infants with severe aortic valve stenosis?
Does percutaneous balloon dilatation reduce aortic valve pressure gradients and improve clinical outcomes in neonates and infants with severe aortic valve stenosis?
Answers are grounded in this paper and cite their sources.
Percutaneous balloon dilatation can successfully reduce aortic valve gradients and provide lasting clinical improvement in neonates and infants with severe stenosis, though the procedure carries significant mortality risks.
Percutaneous balloon dilatation of severe aortic valve stenosis was attempted in thirteen patients (seven neonates and six infants). In two the valve could not be crossed and both died during subsequent operation. Two patients died during manipulation of the balloon catheter. No significant benefit was obtained in another patient who later died during operation. Balloon dilatation was successful in the remaining eight patients, reducing the aortic valve pressure gradient from a mean of 63 mmHg (95% confidence interval 38 to 88 mmHg) to a mean of 23 mmHg (95% confidence interval 7 to 39 mmHg). Two of these patients subsequently died from heart failure related to other cardiac lesions. The six survivors have done well. At follow up the maximum Doppler velocities in the ascending aorta ranged from 1.9 to 4.0 m/s after 2-23 months, but despite this evidence of an increasing valve gradient there has been lasting clinical improvement.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: